The Free Sale Certificate for Device Registration in Guatemala

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Guatemalan device registrations require a free sale certificate (Certificado de Libre Venta), which must be issued by the competent health authority of the country of origin; the basis is Article 5.1.5 of NT 37 Versión 5-2016. The document must be an original (an original may be replaced by a notarially certified copy, Article 5.2.1), must be valid on the day of submission (Article 5.2.2), documents issued abroad must complete Guatemala’s legality requirements (Article 5.2.4), and documents not in Spanish must be translated by a sworn translator authorised in the Republic of Guatemala (Article 5.2.5). The reagent channel under Article 4.1 of NT-40 does not require a free sale certificate. Because the certificate is issued by a foreign authority and then has to survive a chain of legalisation, translation and validity checks, it is usually the document with the longest external lead time in the device dossier, and it should be commissioned earlier than any other paper in the file. Its expiry, moreover, is treated more severely than most dossier defects, as the analysis below shows.

2. Legal basis

The requirements applicable to the free sale certificate and the consequences of its lapse are set out in the following provisions.

DocumentProvisionContent
NT 37, Versión 5-2016 (2016-02-22)Article 5.1.5A free sale certificate issued by the competent health authority of the country of origin
NT 37, Versión 5-2016Article 5.2.1The «original» mentioned in the provision may be replaced by a notarially certified copy (fotocopia legalizada notarialmente)
NT 37, Versión 5-2016Article 5.2.2The document must be valid on the day of the submission window
NT 37, Versión 5-2016Article 5.2.4Documents issued abroad must satisfy Guatemala’s statutory requirements in order to be valid
NT 37, Versión 5-2016Article 5.2.5Documents not in Spanish must be translated by a sworn translator authorised in the Republic of Guatemala
NT 37, Versión 5-2016Article 5.2.6Documents that do not state a validity period are accepted for at most 2 years from the date of issue
NT 37, Versión 5-2016Article 10.3Where the free sale certificate has expired, no registration is granted
NT 40, Versión 3-2015Article 4.1The reagent document checklist does not list the free sale certificate

3. Expert insights

Insight one: the issuing body must be the competent health authority of the country of origin. The wording of Article 5.1.5 is «emitido por la autoridad SANITARIA competente», with the word SANITARIA emphasised in capitals in the original text. Sales certificates issued by industry associations, chambers of commerce or third-party certification bodies do not satisfy this wording; only documents issued by the competent health authority, such as the national drug regulatory authority, count. Companies should verify the issuing body before commissioning the document, because a certificate from the wrong kind of issuer cannot be repaired by legalisation or translation.

Insight two: Article 10.3 lists expiry as an independent ground for refusing registration. The expiry of the free sale certificate appears in Article 10.3 alongside the expiry of the certificate of manufacturing guarantee and the expiry of the power of attorney, and it directly results in the registration being refused. This is not a minor defect that can be corrected by supplementing the file afterwards; it is a milestone that must be tightly controlled in the project schedule from the moment the issuance request is lodged with the foreign authority, because the certificate is a validity-critical document whose lapse cannot be remedied after the fact.

Insight three: Article 5.2.6 gives documents without a validity period a 2-year ceiling. If the certificate as issued does not state a validity period, the authority accepts it for at most 2 years counted from the date of issue. This provision means that «no stated validity» does not mean «valid indefinitely», and the timing of obtaining the document cannot be relaxed on the assumption that an undated certificate keeps forever. The same caution applies to planning renewals, where an old certificate may no longer be usable even though it never declared an expiry date.

Insight four: reagents do not need the free sale certificate, and this is part of the channel difference. The six items in Article 4.1 of NT-40 do not include this document; the emphasis falls on the quality control certificate (Article 4.1.4) and the certificate of manufacturing guarantee (Article 4.1.5). Applying the device checklist to a reagent submission means filing a certificate that was never requested, adding translation and legalisation costs for nothing and lengthening the preparation timeline without any benefit whatsoever.

4. Practical recommendations

  • Before obtaining the certificate, confirm that the country of origin has a competent health authority able to issue it; industry body documents are not an acceptable substitute.
  • Schedule the issuance date of the free sale certificate within the 3 months before submission, to avoid triggering Article 10.3.
  • Process the Hague apostille for foreign documents in parallel (applicable to Guatemala since 2017-09-18) together with the other statutory requirements.
  • Arrange in advance for the translation of non-Spanish versions by a sworn translator authorised in Guatemala.
  • Do not prepare a free sale certificate for reagent projects; put the resources into the quality control and manufacturing guarantee certificates instead.

5. Verification checklist

  • □ The issuing body is the competent health authority of the country of origin
  • □ The document is an original or a notarially certified copy
  • □ The document is still valid on the day of submission
  • □ The foreign document has completed Guatemala’s statutory requirements
  • □ The non-Spanish document has been translated by a sworn translator
  • □ Documents without a stated validity period have not exceeded 2 years from issue
  • □ This certificate has not been mistakenly filed for reagent projects

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail